🔬
Diagnostics
Diagnostic platforms including liquid biopsy, molecular diagnostics, companion diagnostics, and AI-powered screening.
Companies
0
Pipeline Drugs
105
Key People
56
Diagnostics Pipeline (105 drugs)
Commercial: 80Development: 4Approved/Commercial: 4Development/Commercial: 3Research/Development: 3Various: 2Service/Product: 2Product: 2Approved: 2Launch: 1Clinical Development: 1Platform Technology: 1
| Drug | Company | Indication | Phase |
|---|---|---|---|
| Alzheimer's Disease Program | Roche | Alzheimer's Disease | Various |
| Neurological Disorders Portfolio | Roche | Multiple neurological conditions | Various |
| Oncology Pipeline | Roche | Various cancer types | Commercial |
| Diagnostic Solutions | Roche | Disease prevention and detection | Commercial |
| Infinity II LC Systems | Agilent Technologies | Drug discovery and development | Commercial |
| 6500 Series LC-MS/MS | Agilent Technologies | Clinical diagnostics | Commercial |
| SureSelect Target Enrichment | Agilent Technologies | Cancer genomics | Commercial |
| Bravo NGS Workstation | Agilent Technologies | NGS sample preparation | Commercial |
| Seahorse XF Analyzers | Agilent Technologies | Cell metabolism analysis | Commercial |
| PARiS Platform | Agilent Technologies | Pathology AI solutions | Commercial |
| Cologuard | Exact Sciences | Colorectal Cancer Screening | Commercial |
| Cologuard Plus | Exact Sciences | Enhanced Colorectal Cancer Screening | Development |
| Cancerguard | Exact Sciences | Multi-Cancer Early Detection | Commercial |
| Oncotype DX Breast | Exact Sciences | Breast Cancer Treatment Guidance | Commercial |
| Oncotype DX Colon | Exact Sciences | Colon Cancer Treatment Guidance | Commercial |
| Oncotype DX Prostate | Exact Sciences | Prostate Cancer Treatment Guidance | Commercial |
| ctDNA Monitoring | Exact Sciences | Cancer Recurrence Monitoring | Development |
| Detection Platforms | Revvity | Research Analytics | Commercial |
| Imaging Solutions | Revvity | Cell Analysis | Commercial |
| Laboratory Automation | Revvity | Workflow Optimization | Commercial |
| Diagnostic Systems | Revvity | Clinical Testing | Commercial |
| QuantiFERON-TB Gold Plus | Qiagen | Tuberculosis Testing | Commercial |
| QIAstat-Dx Syndromic Testing | Qiagen | Infectious Disease | Commercial |
| therascreen Solid Tumor | Qiagen | Oncology | Commercial |
| ipsogen Leukemia | Qiagen | Leukemia | Commercial |
| QIAcuityDx | Qiagen | Clinical Digital PCR | Commercial |
| QIAsprint Connect | Qiagen | High-throughput Sample Preparation | Launch |
| QIAsymphony Connect | Qiagen | Automated Clinical Sample Extraction | Development |
| QIAseq xHYB Viral and Bacterial Panels | Qiagen | Viral and Bacterial Detection | Commercial |
| QIAstat-Dx Viral Vesicular Panel | Qiagen | Mpox Virus Detection | Commercial |
| Evercode Single-cell RNA-seq | Qiagen | Single-cell Analysis | Commercial |
| Routine Laboratory Testing | Synlab | General health screening and disease monitoring | Commercial |
| Chronic Kidney Disease Diagnostics | Synlab | Early detection and monitoring of CKD | Commercial |
| Rare Disease Diagnostics | Synlab | Genetic and molecular diagnosis of rare conditions | Commercial |
| Pre-Implantation Genetic Testing | Synlab | Genetic screening of embryos before IVF | Commercial |
| Personalized Diagnostics | Synlab | Tailored testing based on individual patient profiles | Commercial |
| Fluent® Automation Workstation | Tecan | Life Sciences Research, Drug Discovery, Diagnostics | Commercial |
| Veya® Multiomics Suites | Tecan | Genomics, Proteomics, Multiomics Research | Commercial |
| Freedom EVO® / Freedom EVOlyzer® | Tecan | Life Sciences, Diagnostics, Applied Markets | Commercial |
| Spark® / Spark® Cyto Microplate Readers | Tecan | Cell-based assays, Drug discovery, Microbiology | Commercial |
| Infinite® 200 PRO / F50 Series | Tecan | Life Sciences Research, Assay Development | Commercial |
| MagicPrep NGS | Tecan | Next-Generation Sequencing Library Preparation | Commercial |
| D300e Digital Dispenser | Tecan | High-Throughput Screening, Drug Discovery | Commercial |
| Duo Digital Dispenser | Tecan | High-Throughput Screening, Drug Discovery | Commercial |
| Resolvex® Positive Pressure Workstations | Tecan | Clinical Mass Spectrometry, Sample Preparation | Commercial |
| Immunoassay Automation Solutions | Tecan | Autoimmunity, Endocrinology, Infectious Disease Diagnostics | Commercial |
| Anti-Vitamin D (25-OH) Antibody | Bioventix | Vitamin D Status Testing | Commercial |
| Anti-Troponin I Antibody | Bioventix | Myocardial Infarction (Cardiac Testing) | Development/Commercial |
| Anti-PSA Antibody | Bioventix | Prostate Cancer Screening | Development/Commercial |
| Anti-SARS-CoV-2 Antibody | Bioventix | COVID-19 Antigen Detection | Commercial |
Key People in Diagnostics
DT
Dr. Thomas Schinecker
Chief Executive Officer, Roche Group
Roche
DS
Dr. Severin Schwan
Chairman of the Board
Roche
AH
André Hoffmann
Vice Chairman of the Board
Roche
TG
Teresa Graham
CEO, Roche Pharmaceuticals
Roche
MS
Matt Sause
CEO, Roche Diagnostics
Roche
DA
Dr. Alan Hippe
Chief Financial Officer
Roche
CA
Cristina A. Wilbur
Chief People Officer
Roche
CB
Claudia Böckstiegel
General Counsel
Roche
DL
Dr. Levi Garraway
Head of Global Product Development and Chief Medical Officer
Roche
SH
Silke Hörnstein
Head of Corporate Strategy and Sustainability
Roche
WM
Wafaa Mamilli
Chief Digital and Technology Officer
Roche
DA
Dr. Aviv Regev
Head of Genentech Research and Early Development
Roche
NS
Nina Schwab-Hautzinger
Head of Group Communications
Roche
BL
Boris L. Zaïtra
Head of Corporate Business Development
Roche
DJ
Dr. Jörg Duschmalé
Board Member
Roche